Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Hearing Loss, Noise-Induced

• FX-322 in Adults With Acquired Sensorineural Hearing Loss
• Noise-Induced Hearing Loss-Acute Exposure Treatment (UA)
• Noise-Induced Hearing Loss-Acute Exposure Treatment
• Verification of the Efficacy/Safety of the Dual Drug Delivery for Hearing Loss
• FX-322 in Adults With Severe Sensorineural Hearing Loss
• FX-322 in Adults With Age-Related Sensorineural Hearing Loss
• FX-322 in Adults With Stable Sensorineural Hearing Loss
• Improvement of Tinnitus After Oral Zinc on Patients With Noise-induced Hearing Loss
• Phase 3 Clinical Trial: D-methionine to Reduce Noise-Induced Hearing Loss (NIHL)
• A Phase 2b Study of SPI-1005 to Prevent Acute Noise Induced Hearing Loss
• Study to Determine the Safety, Tolerability, and Pharmacokinetic Profile of HPN-07 and HPN-07 Plus NAC
• Protective Effects of EPI-743 on Noise-Induced Hearing Loss
• Prevention of Noise-induced Hearing Loss
• Prevention of Noise-induced Damage by Use of Antioxidants
• Phase 3 Clinical Trial: D-methionine to Reduce Noise-Induced Hearing Loss (NIHL)
• Micronutrients to Prevent Noise-induced Hearing Loss
• Antioxidation Medication for Noise-induced Hearing Loss